Document Detail


Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China.
MedLine Citation:
PMID:  20104104     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To demonstrate that the use of highly active antiretroviral therapy (HAART) to interrupt transmission of HIV-1 from mother to baby is effective, safe, and feasible in a remote rural region of China.
METHODS: Between November 2005 and May 2009, we enrolled 279 HIV-1-infected pregnant women to receive HAART to interrupt transmission of HIV-1 to their newborns across 16 counties in Yunnan. All women were started on triple combination therapy and submitted to regular blood draws to monitor CD4 T cells and viral load in their blood plasma. Infants received a single dose of nevirapine at birth and 1 or 4 weeks of zidovudine depending on the length of the mother's regimen. Exclusive formula feeding was recommended, and families were provided with 12-month supply of formula. Mothers and infant pairs were followed for 12-18 months postdelivery.
RESULTS: Of 279 enrolled HIV-infected women, 222 (79.6%) were identified and started treatment by 28 weeks of pregnancy. Viral load was undetectable at time of delivery for 62.4% (136 of 218) at delivery, with a mean 1.76 log viral load reduction between enrollment and delivery. Two of 193 babies (1.0%) who have already been tested became infected with HIV-1. Seven of 223 babies have died. By Kaplan-Meier analysis, cumulative one-year survival was 96.3%.
CONCLUSIONS: The project demonstrated that HAART for all infected pregnant women is effective with a vertical transmission rate of approximately 1%. Thus, this project provides a model for China to scale up its efforts to prevent mother-to-child transmission of HIV-1.
Authors:
Zengquan Zhou; Kathrine Meyers; Xia Li; Qingling Chen; Haoyu Qian; Yunfei Lao; Elvin Geng; Yishan Fan; Shaomin Yang; Michael Chiu; David D Ho
Related Documents :
22718704 - Urinary sodium to creatinine ratio in healthy infants.
20064134 - Factors determining hiv viral testing of infants in the context of mother-to-child tran...
23478874 - Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia.
23360024 - Role of protein rich maternal diet in infantile colic.
22144934 - Dexmedetomidine as the primary anesthetic agent during cardiac surgery in an infant wit...
21528074 - Assay of ghrelin concentration in infant formulas and breast milk.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of acquired immune deficiency syndromes (1999)     Volume:  53 Suppl 1     ISSN:  1944-7884     ISO Abbreviation:  J. Acquir. Immune Defic. Syndr.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-01-27     Completed Date:  2010-02-23     Revised Date:  2013-07-17    
Medline Journal Info:
Nlm Unique ID:  100892005     Medline TA:  J Acquir Immune Defic Syndr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S15-22     Citation Subset:  IM; X    
Affiliation:
Yunnan AIDS Care Center, Kunming, China. ynzzq@263.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Anti-HIV Agents / therapeutic use*
Antiretroviral Therapy, Highly Active*
China / epidemiology
Female
HIV Infections / drug therapy*,  prevention & control*,  transmission
HIV-1 / drug effects*
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical / prevention & control*
Pregnancy
Rural Population
Time Factors
Young Adult
Chemical
Reg. No./Substance:
0/Anti-HIV Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reliability and validity of the Chinese version of the addiction severity index.
Next Document:  Safety of the blood supply in a rural area of China.